Physitrack PLC is a digital healthcare provider, focused on B2B physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World.
2012
85
LTM Revenue $190M
LTM EBITDA $49.0M
$24.5M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Physitrack has a last 12-month revenue of $190M and a last 12-month EBITDA of $49.0M.
In the most recent fiscal year, Physitrack achieved revenue of $1.6M and an EBITDA of -$0.2M.
Physitrack expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Physitrack valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $1.5M | $1.6M | XXX | XXX | XXX |
Gross Profit | $1.2M | n/a | XXX | XXX | XXX |
Gross Margin | 82% | NaN% | XXX | XXX | XXX |
EBITDA | $0.7M | -$0.2M | XXX | XXX | XXX |
EBITDA Margin | 47% | -13% | XXX | XXX | XXX |
Net Profit | $9K | $0.3M | XXX | XXX | XXX |
Net Margin | 1% | 20% | XXX | XXX | XXX |
Net Debt | $25K | $0.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Physitrack's stock price is SEK 12 (or $1).
Physitrack has current market cap of SEK 202M (or $20.0M), and EV of SEK 247M (or $24.5M).
See Physitrack trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$24.5M | $20.0M | XXX | XXX | XXX | XXX | $-0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Physitrack has market cap of $20.0M and EV of $24.5M.
Physitrack's trades at 1.4x LTM EV/Revenue multiple, and 5.4x LTM EBITDA.
Analysts estimate Physitrack's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Physitrack and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $24.5M | XXX | XXX | XXX |
EV/Revenue | 15.3x | XXX | XXX | XXX |
EV/EBITDA | -118.4x | XXX | XXX | XXX |
P/E | -31.2x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -679.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPhysitrack's NTM/LTM revenue growth is -1%
Physitrack's revenue per employee for the last fiscal year averaged $19K, while opex per employee averaged $20K for the same period.
Over next 12 months, Physitrack's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Physitrack's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Physitrack and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 7% | XXX | XXX | XXX | XXX |
EBITDA Margin | -13% | XXX | XXX | XXX | XXX |
EBITDA Growth | -129% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -14% | XXX | XXX | XXX | XXX |
Revenue per Employee | $19K | XXX | XXX | XXX | XXX |
Opex per Employee | $20K | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 103% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
MedAdvisor | XXX | XXX | XXX | XXX | XXX | XXX |
Oneview Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
Life Semantics | XXX | XXX | XXX | XXX | XXX | XXX |
Kooth | XXX | XXX | XXX | XXX | XXX | XXX |
Alignment Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Physitrack acquired XXX companies to date.
Last acquisition by Physitrack was XXXXXXXX, XXXXX XXXXX XXXXXX . Physitrack acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Physitrack founded? | Physitrack was founded in 2012. |
Where is Physitrack headquartered? | Physitrack is headquartered in Sweden. |
How many employees does Physitrack have? | As of today, Physitrack has 85 employees. |
Is Physitrack publicy listed? | Yes, Physitrack is a public company listed on STO. |
What is the stock symbol of Physitrack? | Physitrack trades under PTRK ticker. |
When did Physitrack go public? | Physitrack went public in 2021. |
Who are competitors of Physitrack? | Similar companies to Physitrack include e.g. MedAdvisor, Oneview Healthcare, Life Semantics, Kooth. |
What is the current market cap of Physitrack? | Physitrack's current market cap is $20.0M |
What is the current revenue of Physitrack? | Physitrack's last 12-month revenue is $190M. |
What is the current EBITDA of Physitrack? | Physitrack's last 12-month EBITDA is $49.0M. |
What is the current EV/Revenue multiple of Physitrack? | Current revenue multiple of Physitrack is 1.4x. |
What is the current EV/EBITDA multiple of Physitrack? | Current EBITDA multiple of Physitrack is 5.4x. |
What is the current revenue growth of Physitrack? | Physitrack revenue growth between 2023 and 2024 was 7%. |
Is Physitrack profitable? | Yes, Physitrack is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.